carbapenems has been researched along with Burkholderia pseudomallei Infection in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Deris, ZZ; Harun, A; Hasan, H; Muhd Besari, A; Zamani, A; Zueter, AR | 1 |
| Dance, D | 1 |
| Nilsakul, J; Panomket, P; Panya, M; Thirat, S; Wanram, S | 1 |
| Apisarnthanarak, A; Kiratisin, P; Laowansiri, P; Shah, S | 1 |
| Engler, C; Harris, P; Norton, R | 1 |
| Limmathurotsakul, D; Peacock, SJ | 1 |
| De Smet, B; Jacobs, J; Kham, C; Koole, O; Kruy, L; Lynen, L; Phe, T; Thai, S; Veng, CH; Vlieghe, E | 1 |
| Miyagi, K; Saito, A | 1 |
3 review(s) available for carbapenems and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
Treatment and prophylaxis of melioidosis.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Melioidosis; Sulfamethoxazole; Trimethoprim | 2014 |
Melioidosis: a clinical overview.
Topics: Anti-Infective Agents; Asia, Southeastern; Australia; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Communicable Disease Control; Disease Reservoirs; Global Health; Humans; Melioidosis; Recurrence; Risk Assessment; Sepsis; Seroepidemiologic Studies; Serologic Tests | 2011 |
[Melioidosis].
Topics: 4-Quinolones; Anti-Infective Agents; Burkholderia pseudomallei; Carbapenems; Cephalosporins; Diagnosis, Differential; Drug Resistance, Bacterial; Humans; Melioidosis | 2003 |
5 other study(ies) available for carbapenems and Burkholderia pseudomallei Infection
| Article | Year |
|---|---|
Reduced susceptibility of Burkholderia pseudomallei following exposure to carbapenem.
Topics: Burkholderia pseudomallei; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged | 2020 |
Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Humans; Imipenem; Melioidosis; Microbial Sensitivity Tests; Prevalence; Real-Time Polymerase Chain Reaction; Thailand | 2016 |
A role for carbapenem in the treatment of melioidosis in developing countries?
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Carbapenems; Debridement; Developing Countries; Humans; Leg; Male; Melioidosis; Meropenem; Middle Aged; Thailand; Thienamycins; Treatment Outcome | 2009 |
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Burkholderia pseudomallei; Carbapenems; Doripenem; Ertapenem; Fluoroquinolones; Humans; Melioidosis; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline | 2011 |
Melioidosis, phnom penh, Cambodia.
Topics: Adolescent; Adult; Aged; Burkholderia pseudomallei; Cambodia; Carbapenems; Cephalosporins; Diabetes Mellitus, Type 2; Diagnostic Errors; Doxycycline; Female; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Sulfamethoxazole; Survival Rate; Trimethoprim | 2011 |